CareDx (CDNA) Fundamental Analysis: Revenue, Earnings & Valuation

6.73 / 10

Outperform

Fundamentally, CDNA scores 6.7/10 and is rated Outperform. Profit‑MV (+0.68) and Cash‑UP (-0.84) are bullish, whereas Cash‑MV (-0.48) and Asset‑MV (-0.55) drag performance. ROE and ROA are modestly negative but sit in mid‑range groups, yielding modest returns.

Analysis Checks(8/10)

ROA (%)

Value-4.72

Score2/3

Weight24.50%

1M Return0.63%

Annualized return on equity (%)

Value-6.27

Score2/3

Weight54.39%

1M Return1.35%

Profit-MV

Value0.68

Score2/3

Weight136.15%

1M Return3.26%

Cash-UP

Value-0.84

Score2/3

Weight-124.17%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-4.72

Score2/3

Weight24.50%

1M Return0.63%

ROE (diluted) (%)

Value-7.05

Score2/3

Weight44.10%

1M Return1.11%

Asset-MV

Value-0.55

Score1/3

Weight25.74%

1M Return0.71%

ROE (%)

Value-6.27

Score2/3

Weight54.39%

1M Return1.35%

Cash-MV

Value-0.48

Score1/3

Weight-107.04%

1M Return-3.56%

Net profit / Total profit (%)

Value101.29

Score2/3

Weight-32.55%

1M Return-0.89%

Is CDNA fundamentally strong?

CDNA scores 6.73/10 on fundamentals and holds a Discounted valuation at present. Backed by its -6.27% ROE, -5.62% net margin, -40.25 P/E ratio, 2.84 P/B ratio, and -140.00% earnings growth, these metrics solidify its Outperform investment rating.